Products and services > owl liver > Information for physicians > Patents

Patents concerning owl liver

OWL Genomics has developed a blood based test for Steatosis and NASH diagnosis. It is a non-invasive effective method.

 

The identification and validation of metabolic and proteomic markers is the core of this innovative method, which is included on two patents applications presented in 2008:

  • EP 08380249.6

    "Method for the diagnosis of Non Alcoholic steatohepatitis (NASH) using metabolic profiles":

  • EP 08380196.9

    "Proteomic fingerprint for the diagnosis of Non Alcoholic steatohepatitis (NASH) and/or steatosis":

Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
Phone: +34 94 431 85 40
Fax: +34 94 431 71 40

With this web OWL Genomics intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a qualified
physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 09/06/2010

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.